gold has been researched along with bucillamine in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Funakoshi, T; Kiyozumi, M; Kojima, S; Shimada, H; Takahashi, Y | 1 |
Ishikawa, K; Sakaguchi, M | 1 |
Abe, T | 1 |
Brooks, P; Conaghan, PG | 1 |
Brooks, P; Conaghan, PG; Girgis, L | 1 |
2 review(s) available for gold and bucillamine
Article | Year |
---|---|
Disease-modifying antirheumatic drugs, including methotrexate, gold, antimalarials, and D-penicillamine.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antimalarials; Antirheumatic Agents; Arthritis, Rheumatoid; Clinical Trials as Topic; Cysteine; Drug Therapy, Combination; Gold; Humans; Methotrexate; Penicillamine; Sulfasalazine | 1995 |
Disease-modifying antirheumatic drugs, including methotrexate, sulfasalazine, gold, antimalarials, and penicillamine.
Topics: Age Factors; Antimalarials; Arthritis, Rheumatoid; Clinical Trials as Topic; Cysteine; Digestive System; Gold; Humans; Liver; Methotrexate; Penicillamine; Sulfasalazine | 1994 |
1 trial(s) available for gold and bucillamine
Article | Year |
---|---|
SA 96 (N-(2-mercapto-2-methylpropanoyl)-L-cysteine) in rheumatoid arthritis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Cysteine; Drug Eruptions; Elasticity; Female; Gold; Humans; Middle Aged; Penicillamine; Tensile Strength; Time Factors | 1986 |
2 other study(ies) available for gold and bucillamine
Article | Year |
---|---|
Characterization of gold in urine and bile following administration of gold sodium thiomalate with chelating agents to rats.
Topics: Animals; Bile; Chelating Agents; Chromatography; Cysteine; Electrophoresis; Gold; Gold Sodium Thiomalate; Injections, Intravenous; Male; Penicillamine; Rats; Rats, Inbred Strains; Succimer; Unithiol | 1992 |
[Trends in the development of immunomodulators based physiopathological mechanisms of various types of hypersensitivities].
Topics: Adjuvants, Immunologic; Animals; Cysteine; Female; Gold; Hypersensitivity; Immunosuppressive Agents; Immunotherapy; Levamisole; Male; Mice; ortho-Aminobenzoates | 1983 |